ICAM1 and endothelial dysfunction: Current evidence suggests that concomitant administration of metformin during radiotherapy in rats decreases the expression of E-selectin, ICAM-1, and VCAM-1, thereby acting as a potent heart protector from endothelial dysfunction-induced damage (Karam and Radwan, 2019).